METTL5 and pancreatic adenocarcinoma: Furthermore, upregulated METTL5 expressions were observed in OC, large B‐cell Lymphoma (DLBC), thymoma (THYM), liver hepatocellular carcinoma (LIHC), pancreatic adenocarcinoma (PAAD), and kidney renal clear cell carcinoma (KIRC) compared to corresponding normal tissues (Figure 2C).